|
SUPV3L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.77279985031009E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.5579000312016E-09 |
| Normal-vs-Stage2 |
2.442500E-03 |
| Normal-vs-Stage3 |
1.385140E-04 |
| Normal-vs-Stage4 |
1.583640E-01 |
| Stage1-vs-Stage2 |
5.994200E-01 |
| Stage1-vs-Stage3 |
9.734800E-01 |
| Stage1-vs-Stage4 |
5.346800E-01 |
| Stage2-vs-Stage3 |
6.356200E-01 |
| Stage2-vs-Stage4 |
8.461800E-01 |
| Stage3-vs-Stage4 |
5.945200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68389968635552E-10 |
| Normal-vs-AfricanAmerican |
1.202130E-04 |
| Normal-vs-Asian |
8.912800E-01 |
| Caucasian-vs-AfricanAmerican |
4.425600E-01 |
| Caucasian-vs-Asian |
3.891600E-01 |
| AfricanAmerican-vs-Asian |
2.625800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01120231579921E-11 |
| Normal-vs-Female |
5.167000E-04 |
| Male-vs-Female |
1.106230E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.89679999999771E-05 |
| Normal-vs-Extreme_Weight |
1.99610328266431E-11 |
| Normal-vs-Obese |
7.70919999948383E-07 |
| Normal-vs-Extreme_Obese |
6.379200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.947970E-01 |
| Normal_Weight-vs-Obese |
9.795400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.388000E-01 |
| Extreme_Weight-vs-Obese |
1.054450E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.500000E-01 |
| Obese-vs-Extreme_Obese |
4.284800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.194800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.76299991167173E-10 |
| Normal-vs-Age(61-80Yrs) |
7.15570003251287E-09 |
| Normal-vs-Age(81-100Yrs) |
4.74829997543225E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.588100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.534400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.735100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.397200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.897810E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.142300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.25120041999583E-10 |
| Normal-VS-Type2 PRCC |
2.98669999998502E-06 |
| Normal-VS-KIRP CIMP |
5.598600E-01 |
| Normal-VS-Unclassified PRCC |
1.61729996062121E-09 |
| Type1 PRCC-VS-Type2 PRCC |
5.440200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.077200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.997800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.912800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.969400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.607450E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.79549980123306E-10 |
| Normal-vs-N1 |
1.250140E-02 |
| Normal-vs-N2 |
1.256570E-01 |
| N0-vs-N1 |
1.789970E-01 |
| N0-vs-N2 |
4.081200E-01 |
| N1-vs-N2 |
2.586200E-01 |
|
|
